UNSPSC 51282930: Miloxacin

This classification denotes an antibiotic with the molecular formula C12H9NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VM4W7043SN, chemically known as 5,8-dihydro-5-methoxy-8-oxo-2h-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid but generally known as miloxacin, which bears US NIH Compound Identifier 37614. European Medicines Agency schedules Miloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08967MIG.

UNSPSC 51282930 Miloxacin, a Commodity code, shows minimal recent state and local procurement activity aligned with its stated scope. The two opportunities tagged to this code involve pharmaceutical procurement through state and local health agencies, but neither involves miloxacin specifically — one covers antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) through a consortium piggyback award, and the other covers naloxone and drug deactivation systems through a county health program. The code's nominal scope and the actual work being bought do not align; miloxacin-specific solicitations do not appear in the recent record.

The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse consortium under an Invitation for Bid process (Solicitation 26482DPHPREPDB53392) — a completed award, not an open opportunity. Seminole County, Florida issued an IFB (IFB60459723LAS) with a July 26, 2023 response deadline for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems for quarterly delivery to the county's community health building, with potential FEMA funding and a two-year term plus one-year renewal option. State and local health departments and county health authorities appear to be the primary issuing bodies under this code, but the current record offers no active, open solicitations for miloxacin or meaningful pipeline visibility into future demand.